Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 7.86 USD -0.25% Market Closed
Market Cap: 424.3m USD

Relative Value

The Relative Value of one FULC stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.86 USD, Fulcrum Therapeutics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FULC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
49
Median 3Y
32.5
Median 5Y
37.5
Industry
2.5
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.1
Industry
21.6
Forward
-6.6
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.3
Industry
16.7
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.2
Industry
24
vs History
55
vs Industry
68
Median 3Y
1.4
Median 5Y
1.9
Industry
2.2
vs History
69
vs Industry
3
Median 3Y
3.2
Median 5Y
13.8
Industry
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.3
vs History
vs Industry
49
Median 3Y
-0.8
Median 5Y
-2.1
Industry
12.9
Forward
-2.1
vs History
vs Industry
48
Median 3Y
-0.7
Median 5Y
-2
Industry
16.3
Forward
-2.1
vs History
vs Industry
14
Median 3Y
-1
Median 5Y
-2.6
Industry
15.2
vs History
vs Industry
18
Median 3Y
-1
Median 5Y
-2.6
Industry
17.7
vs History
47
vs Industry
6
Median 3Y
4.1
Median 5Y
9.7
Industry
1.9

Multiples Across Competitors

FULC Competitors Multiples
Fulcrum Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Fulcrum Therapeutics Inc
NASDAQ:FULC
424.2m USD 5.3 -43.6 -10 -9.2
US
Eli Lilly and Co
NYSE:LLY
722.7B USD 14.8 65.2 35 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
393.4B USD 4.4 18 13.2 17.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.2 18 12.5 14.3
CH
Roche Holding AG
SIX:ROG
204.4B CHF 3.4 24.7 9.3 10.9
CH
Novartis AG
SIX:NOVN
182.4B CHF 4.3 17.8 10.5 14
UK
AstraZeneca PLC
LSE:AZN
159.9B GBP 3.9 27.6 130.5 196.8
US
Merck & Co Inc
NYSE:MRK
205.1B USD 3.2 11.8 8.7 10.6
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.8B USD 2.2 17.7 7.6 10.7
P/E Multiple
Earnings Growth PEG
US
Fulcrum Therapeutics Inc
NASDAQ:FULC
Average P/E: 25.1
Negative Multiple: -43.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
65.2
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
18
27%
0.7
DK
Novo Nordisk A/S
CSE:NOVO B
18
18%
1
CH
Roche Holding AG
SIX:ROG
24.7
32%
0.8
CH
Novartis AG
SIX:NOVN
17.8
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.6
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Fulcrum Therapeutics Inc
NASDAQ:FULC
Average EV/EBITDA: 436.6
Negative Multiple: -10
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.2
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.5
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.5
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Fulcrum Therapeutics Inc
NASDAQ:FULC
Average EV/EBIT: 1 874.8
Negative Multiple: -9.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.3
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.3
14%
1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.8
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1